Platform
Disease specific
AppMed’s platform is specific to a health condition or disease state. The targeted therapeutic states include hard to dose/titrate medication therapy and one with narrow therapeutic index. Narrow therapeutic index refers to the small range between the minimum effective dose and the toxic dose of a medication or otherwise defined by the dosage range in which a drug is effective without causing serious side effects or toxicity.
Diseases covered
AppMed is currently covering the following diseases:
- Attention Deficit Hyperactive Disorder (ADHD)
- Immunosuppressive treatment in the context of anti-rejection therapy post organ transplantation
- Opioid pain management in post-surgical setting
It is not without saying that our platform could potentially
be expanded in psychiatry, oncology, neurology and more.
INTRODUCTING APPMED’S PLATFORM
ROBUST
Our digital platform is a robuste, stand-alone, web-based solution designed for seamless multi-platform operation. It enables the onboarding of multiple healthcare professionals (HCPs) who collaborate in treating the same patient, ensuring a comprehensive approach to patient care.
EASY TO USE
Patient results are consolidated into a single, intuitive dashboard, allowing for easy visualization and understanding. These results can be exported into a PDF report, facilitating efficient intégration with Electronic Medical Records (EMR). The platform empowers patients by providing clear visualization and explanation of their results, fostering engagement and understanding of their treatment plan.
VERSATILE
Key features of our platform include automated billing processes, ensuring streamlided financial management, and a flexible, scalable framework adaptable to various disease states. Additionally, the platform is designed to support clinical research, making it a versatile to for both everyday clinical use and advanced research applications.
PATIENT CENTRIC
Our platform is designed to place patients at the center of their medical treatment. By granting them access to their clinical results from drug surveillance solution, along with clear and concise explanations of these findings, we him to enhance their understanding. Additionally, the platform facilitates real-time, two-way communication with their healthcare providers and offers tailored educational resources related to their specific condition. Our goal is to empower patients to take an active role in managing their therapy and overall health.